C12Y 304/211
Sedolisin
Official title: Sedolisin (3.4.21.100)
C12Y304/211 (Sedolisin) appears on 0 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 6
- Assignees
- 1
- Inventors
- 4
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
No granted patents in this class yet.
- Use of proteolytic enzymes to enhance protein bioavailability14 May 2026US 2026/0130390 A1The Regents of the University of California
- Proteolytic enzymes30 Apr 2026US 2026/0117215 A1
- Use of proteolytic enzymes to enhance protein bioavailability26 Sep 2024US 2024/0315277 A1The Regents of the University of California
- Use of proteolytic enzymes to enhance protein bioavailability9 May 2024US 2024/0148020 A1The Regents of the University of California
- Use of proteolytic enzymes to enhance protein bioavailability16 Dec 2021US 2021/0386089 A1The Regents of the University of California
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.